Global Uterine Fibroids Market Research Report 2023

Uterine fibroids (myoma) are benign (non-cancerous) lumps that grow in the muscular wall of the uterus. They vary in sizes, from minute (a quarter of an inch) to the size of more than16 centimeters. The incidence of uterine fibroid is about 20%–40% in women during their reproductive ages. Occasionally, these fibroids swell up and make the uterus to grow like full visible pregnancy. Mostly, there are more than one fibroid in the uterus. However, fibroids do not always cause any symptoms, their location, and size results to difficulties for few women, including pain, discomfort and heavy bleeding. Uterine fibroid can be of different types such as intramural fibroids, subserosal fibroids, pedunculated fibroids and submucosal fibroids. There can be many reasons for uterine fibroid formation but genetic problems hormonal imbalance and other factors are predominant. The cardinal symptoms of uterine fibroids are heavy menstrual bleeding, abdominal pain, excessive uterine bleeding, increased urinary frequency, anaemia and infertility. Apart from physical morbidity, uterine fibroid ailment is a frequent cause of significant damage of quality of life and a major reason for hysterectomy. Therapy has traditionally based on two extremes: medicinal management, comprising progestins, oral contraceptives and GnRH agonists and surgical management, including myomectomy, hysterectomy, and ablation for most serious cases.

The global Uterine Fibroids market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

Patients suffering from uterine fibroid problem represent an undeserved and huge market due to the absence of satisfactory medical treatments. Uterine fibroids affects nearly 40% of women in the age group of 30 and 55, including 20 million women in North America and 24 million women in Europe with over 7 million patients worldwide presently undergo various symptom management treatments.

This report aims to provide a comprehensive presentation of the global market for Uterine Fibroids, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Uterine Fibroids.

The Uterine Fibroids market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Uterine Fibroids market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Uterine Fibroids companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Uterine Fibroids Market Size Growth Rate by Type: 2018 VS 2022 VS 2029

1.2.2 Non-Hormonal Treatment

1.2.3 Hormonal Treatment

1.3 Market by Application

1.3.1 Global Uterine Fibroids Market Growth by Application: 2018 VS 2022 VS 2029

1.3.2 Hospitals

1.3.3 Ambulatory Surgical Centers

1.3.4 Diagnostic Centers

1.3.5 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2.1 Global Uterine Fibroids Market Perspective (2018-2029)

2.2 Uterine Fibroids Growth Trends by Region

2.2.1 Global Uterine Fibroids Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 Uterine Fibroids Historic Market Size by Region (2018-2023)

2.2.3 Uterine Fibroids Forecasted Market Size by Region (2024-2029)

2.3 Uterine Fibroids Market Dynamics

2.3.1 Uterine Fibroids Industry Trends

2.3.2 Uterine Fibroids Market Drivers

2.3.3 Uterine Fibroids Market Challenges

2.3.4 Uterine Fibroids Market Restraints

3.1 Global Top Uterine Fibroids Players by Revenue

3.1.1 Global Top Uterine Fibroids Players by Revenue (2018-2023)

3.1.2 Global Uterine Fibroids Revenue Market Share by Players (2018-2023)

3.2 Global Uterine Fibroids Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Uterine Fibroids Revenue

3.4 Global Uterine Fibroids Market Concentration Ratio

3.4.1 Global Uterine Fibroids Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Uterine Fibroids Revenue in 2022

3.5 Uterine Fibroids Key Players Head office and Area Served

3.6 Key Players Uterine Fibroids Product Solution and Service

3.7 Date of Enter into Uterine Fibroids Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Uterine Fibroids Historic Market Size by Type (2018-2023)

4.2 Global Uterine Fibroids Forecasted Market Size by Type (2024-2029)

5.1 Global Uterine Fibroids Historic Market Size by Application (2018-2023)

5.2 Global Uterine Fibroids Forecasted Market Size by Application (2024-2029)

6.1 North America Uterine Fibroids Market Size (2018-2029)

6.2 North America Uterine Fibroids Market Growth Rate by Country: 2018 VS 2022 VS 2029

6.3 North America Uterine Fibroids Market Size by Country (2018-2023)

6.4 North America Uterine Fibroids Market Size by Country (2024-2029)

6.5 United States

6.6 Canada

7.1 Europe Uterine Fibroids Market Size (2018-2029)

7.2 Europe Uterine Fibroids Market Growth Rate by Country: 2018 VS 2022 VS 2029

7.3 Europe Uterine Fibroids Market Size by Country (2018-2023)

7.4 Europe Uterine Fibroids Market Size by Country (2024-2029)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8.1 Asia-Pacific Uterine Fibroids Market Size (2018-2029)

8.2 Asia-Pacific Uterine Fibroids Market Growth Rate by Region: 2018 VS 2022 VS 2029

8.3 Asia-Pacific Uterine Fibroids Market Size by Region (2018-2023)

8.4 Asia-Pacific Uterine Fibroids Market Size by Region (2024-2029)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9.1 Latin America Uterine Fibroids Market Size (2018-2029)

9.2 Latin America Uterine Fibroids Market Growth Rate by Country: 2018 VS 2022 VS 2029

9.3 Latin America Uterine Fibroids Market Size by Country (2018-2023)

9.4 Latin America Uterine Fibroids Market Size by Country (2024-2029)

9.5 Mexico

9.6 Brazil

10.1 Middle East & Africa Uterine Fibroids Market Size (2018-2029)

10.2 Middle East & Africa Uterine Fibroids Market Growth Rate by Country: 2018 VS 2022 VS 2029

10.3 Middle East & Africa Uterine Fibroids Market Size by Country (2018-2023)

10.4 Middle East & Africa Uterine Fibroids Market Size by Country (2024-2029)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11.1 Boston Scientific

11.1.1 Boston Scientific Company Detail

11.1.2 Boston Scientific Business Overview

11.1.3 Boston Scientific Uterine Fibroids Introduction

11.1.4 Boston Scientific Revenue in Uterine Fibroids Business (2018-2023)

11.1.5 Boston Scientific Recent Development

11.2 Cooper Surgical

11.2.1 Cooper Surgical Company Detail

11.2.2 Cooper Surgical Business Overview

11.2.3 Cooper Surgical Uterine Fibroids Introduction

11.2.4 Cooper Surgical Revenue in Uterine Fibroids Business (2018-2023)

11.2.5 Cooper Surgical Recent Development

11.3 C.R. Bard

11.3.1 C.R. Bard Company Detail

11.3.2 C.R. Bard Business Overview

11.3.3 C.R. Bard Uterine Fibroids Introduction

11.3.4 C.R. Bard Revenue in Uterine Fibroids Business (2018-2023)

11.3.5 C.R. Bard Recent Development

11.4 F. Hoffmann-La Roche

11.4.1 F. Hoffmann-La Roche Company Detail

11.4.2 F. Hoffmann-La Roche Business Overview

11.4.3 F. Hoffmann-La Roche Uterine Fibroids Introduction

11.4.4 F. Hoffmann-La Roche Revenue in Uterine Fibroids Business (2018-2023)

11.4.5 F. Hoffmann-La Roche Recent Development

11.5 GE Healthcare

11.5.1 GE Healthcare Company Detail

11.5.2 GE Healthcare Business Overview

11.5.3 GE Healthcare Uterine Fibroids Introduction

11.5.4 GE Healthcare Revenue in Uterine Fibroids Business (2018-2023)

11.5.5 GE Healthcare Recent Development

11.6 Karl Storz Endoscopy

11.6.1 Karl Storz Endoscopy Company Detail

11.6.2 Karl Storz Endoscopy Business Overview

11.6.3 Karl Storz Endoscopy Uterine Fibroids Introduction

11.6.4 Karl Storz Endoscopy Revenue in Uterine Fibroids Business (2018-2023)

11.6.5 Karl Storz Endoscopy Recent Development

11.7 Richard Wolf Medical Instruments

11.7.1 Richard Wolf Medical Instruments Company Detail

11.7.2 Richard Wolf Medical Instruments Business Overview

11.7.3 Richard Wolf Medical Instruments Uterine Fibroids Introduction

11.7.4 Richard Wolf Medical Instruments Revenue in Uterine Fibroids Business (2018-2023)

11.7.5 Richard Wolf Medical Instruments Recent Development

11.8 Siemens Medical Solutions

11.8.1 Siemens Medical Solutions Company Detail

11.8.2 Siemens Medical Solutions Business Overview

11.8.3 Siemens Medical Solutions Uterine Fibroids Introduction

11.8.4 Siemens Medical Solutions Revenue in Uterine Fibroids Business (2018-2023)

11.8.5 Siemens Medical Solutions Recent Development

11.9 AbbVie

11.9.1 AbbVie Company Detail

11.9.2 AbbVie Business Overview

11.9.3 AbbVie Uterine Fibroids Introduction

11.9.4 AbbVie Revenue in Uterine Fibroids Business (2018-2023)

11.9.5 AbbVie Recent Development

11.10 AstraZeneca

11.10.1 AstraZeneca Company Detail

11.10.2 AstraZeneca Business Overview

11.10.3 AstraZeneca Uterine Fibroids Introduction

11.10.4 AstraZeneca Revenue in Uterine Fibroids Business (2018-2023)

11.10.5 AstraZeneca Recent Development

11.11 Bayer

11.11.1 Bayer Company Detail

11.11.2 Bayer Business Overview

11.11.3 Bayer Uterine Fibroids Introduction

11.11.4 Bayer Revenue in Uterine Fibroids Business (2018-2023)

11.11.5 Bayer Recent Development

11.12 Eli Lilly

11.12.1 Eli Lilly Company Detail

11.12.2 Eli Lilly Business Overview

11.12.3 Eli Lilly Uterine Fibroids Introduction

11.12.4 Eli Lilly Revenue in Uterine Fibroids Business (2018-2023)

11.12.5 Eli Lilly Recent Development

11.13 GlaxoSmithKline Pharmaceuticals

11.13.1 GlaxoSmithKline Pharmaceuticals Company Detail

11.13.2 GlaxoSmithKline Pharmaceuticals Business Overview

11.13.3 GlaxoSmithKline Pharmaceuticals Uterine Fibroids Introduction

11.13.4 GlaxoSmithKline Pharmaceuticals Revenue in Uterine Fibroids Business (2018-2023)

11.13.5 GlaxoSmithKline Pharmaceuticals Recent Development

11.14 Pfizer

11.14.1 Pfizer Company Detail

11.14.2 Pfizer Business Overview

11.14.3 Pfizer Uterine Fibroids Introduction

11.14.4 Pfizer Revenue in Uterine Fibroids Business (2018-2023)

11.14.5 Pfizer Recent Development

11.15 Johnson & Johnson

11.15.1 Johnson & Johnson Company Detail

11.15.2 Johnson & Johnson Business Overview

11.15.3 Johnson & Johnson Uterine Fibroids Introduction

11.15.4 Johnson & Johnson Revenue in Uterine Fibroids Business (2018-2023)

11.15.5 Johnson & Johnson Recent Development

11.16 Novartis

11.16.1 Novartis Company Detail

11.16.2 Novartis Business Overview

11.16.3 Novartis Uterine Fibroids Introduction

11.16.4 Novartis Revenue in Uterine Fibroids Business (2018-2023)

11.16.5 Novartis Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

    Table 1. Global Uterine Fibroids Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029

    Table 2. Key Players of Non-Hormonal Treatment

    Table 3. Key Players of Hormonal Treatment

    Table 4. Global Uterine Fibroids Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029

    Table 5. Global Uterine Fibroids Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 6. Global Uterine Fibroids Market Size by Region (2018-2023) & (US$ Million)

    Table 7. Global Uterine Fibroids Market Share by Region (2018-2023)

    Table 8. Global Uterine Fibroids Forecasted Market Size by Region (2024-2029) & (US$ Million)

    Table 9. Global Uterine Fibroids Market Share by Region (2024-2029)

    Table 10. Uterine Fibroids Market Trends

    Table 11. Uterine Fibroids Market Drivers

    Table 12. Uterine Fibroids Market Challenges

    Table 13. Uterine Fibroids Market Restraints

    Table 14. Global Uterine Fibroids Revenue by Players (2018-2023) & (US$ Million)

    Table 15. Global Uterine Fibroids Market Share by Players (2018-2023)

    Table 16. Global Top Uterine Fibroids Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Uterine Fibroids as of 2022)

    Table 17. Ranking of Global Top Uterine Fibroids Companies by Revenue (US$ Million) in 2022

    Table 18. Global 5 Largest Players Market Share by Uterine Fibroids Revenue (CR5 and HHI) & (2018-2023)

    Table 19. Key Players Headquarters and Area Served

    Table 20. Key Players Uterine Fibroids Product Solution and Service

    Table 21. Date of Enter into Uterine Fibroids Market

    Table 22. Mergers & Acquisitions, Expansion Plans

    Table 23. Global Uterine Fibroids Market Size by Type (2018-2023) & (US$ Million)

    Table 24. Global Uterine Fibroids Revenue Market Share by Type (2018-2023)

    Table 25. Global Uterine Fibroids Forecasted Market Size by Type (2024-2029) & (US$ Million)

    Table 26. Global Uterine Fibroids Revenue Market Share by Type (2024-2029)

    Table 27. Global Uterine Fibroids Market Size by Application (2018-2023) & (US$ Million)

    Table 28. Global Uterine Fibroids Revenue Market Share by Application (2018-2023)

    Table 29. Global Uterine Fibroids Forecasted Market Size by Application (2024-2029) & (US$ Million)

    Table 30. Global Uterine Fibroids Revenue Market Share by Application (2024-2029)

    Table 31. North America Uterine Fibroids Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 32. North America Uterine Fibroids Market Size by Country (2018-2023) & (US$ Million)

    Table 33. North America Uterine Fibroids Market Size by Country (2024-2029) & (US$ Million)

    Table 34. Europe Uterine Fibroids Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 35. Europe Uterine Fibroids Market Size by Country (2018-2023) & (US$ Million)

    Table 36. Europe Uterine Fibroids Market Size by Country (2024-2029) & (US$ Million)

    Table 37. Asia-Pacific Uterine Fibroids Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 38. Asia-Pacific Uterine Fibroids Market Size by Region (2018-2023) & (US$ Million)

    Table 39. Asia-Pacific Uterine Fibroids Market Size by Region (2024-2029) & (US$ Million)

    Table 40. Latin America Uterine Fibroids Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 41. Latin America Uterine Fibroids Market Size by Country (2018-2023) & (US$ Million)

    Table 42. Latin America Uterine Fibroids Market Size by Country (2024-2029) & (US$ Million)

    Table 43. Middle East & Africa Uterine Fibroids Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 44. Middle East & Africa Uterine Fibroids Market Size by Country (2018-2023) & (US$ Million)

    Table 45. Middle East & Africa Uterine Fibroids Market Size by Country (2024-2029) & (US$ Million)

    Table 46. Boston Scientific Company Detail

    Table 47. Boston Scientific Business Overview

    Table 48. Boston Scientific Uterine Fibroids Product

    Table 49. Boston Scientific Revenue in Uterine Fibroids Business (2018-2023) & (US$ Million)

    Table 50. Boston Scientific Recent Development

    Table 51. Cooper Surgical Company Detail

    Table 52. Cooper Surgical Business Overview

    Table 53. Cooper Surgical Uterine Fibroids Product

    Table 54. Cooper Surgical Revenue in Uterine Fibroids Business (2018-2023) & (US$ Million)

    Table 55. Cooper Surgical Recent Development

    Table 56. C.R. Bard Company Detail

    Table 57. C.R. Bard Business Overview

    Table 58. C.R. Bard Uterine Fibroids Product

    Table 59. C.R. Bard Revenue in Uterine Fibroids Business (2018-2023) & (US$ Million)

    Table 60. C.R. Bard Recent Development

    Table 61. F. Hoffmann-La Roche Company Detail

    Table 62. F. Hoffmann-La Roche Business Overview

    Table 63. F. Hoffmann-La Roche Uterine Fibroids Product

    Table 64. F. Hoffmann-La Roche Revenue in Uterine Fibroids Business (2018-2023) & (US$ Million)

    Table 65. F. Hoffmann-La Roche Recent Development

    Table 66. GE Healthcare Company Detail

    Table 67. GE Healthcare Business Overview

    Table 68. GE Healthcare Uterine Fibroids Product

    Table 69. GE Healthcare Revenue in Uterine Fibroids Business (2018-2023) & (US$ Million)

    Table 70. GE Healthcare Recent Development

    Table 71. Karl Storz Endoscopy Company Detail

    Table 72. Karl Storz Endoscopy Business Overview

    Table 73. Karl Storz Endoscopy Uterine Fibroids Product

    Table 74. Karl Storz Endoscopy Revenue in Uterine Fibroids Business (2018-2023) & (US$ Million)

    Table 75. Karl Storz Endoscopy Recent Development

    Table 76. Richard Wolf Medical Instruments Company Detail

    Table 77. Richard Wolf Medical Instruments Business Overview

    Table 78. Richard Wolf Medical Instruments Uterine Fibroids Product

    Table 79. Richard Wolf Medical Instruments Revenue in Uterine Fibroids Business (2018-2023) & (US$ Million)

    Table 80. Richard Wolf Medical Instruments Recent Development

    Table 81. Siemens Medical Solutions Company Detail

    Table 82. Siemens Medical Solutions Business Overview

    Table 83. Siemens Medical Solutions Uterine Fibroids Product

    Table 84. Siemens Medical Solutions Revenue in Uterine Fibroids Business (2018-2023) & (US$ Million)

    Table 85. Siemens Medical Solutions Recent Development

    Table 86. AbbVie Company Detail

    Table 87. AbbVie Business Overview

    Table 88. AbbVie Uterine Fibroids Product

    Table 89. AbbVie Revenue in Uterine Fibroids Business (2018-2023) & (US$ Million)

    Table 90. AbbVie Recent Development

    Table 91. AstraZeneca Company Detail

    Table 92. AstraZeneca Business Overview

    Table 93. AstraZeneca Uterine Fibroids Product

    Table 94. AstraZeneca Revenue in Uterine Fibroids Business (2018-2023) & (US$ Million)

    Table 95. AstraZeneca Recent Development

    Table 96. Bayer Company Detail

    Table 97. Bayer Business Overview

    Table 98. Bayer Uterine Fibroids Product

    Table 99. Bayer Revenue in Uterine Fibroids Business (2018-2023) & (US$ Million)

    Table 100. Bayer Recent Development

    Table 101. Eli Lilly Company Detail

    Table 102. Eli Lilly Business Overview

    Table 103. Eli Lilly Uterine Fibroids Product

    Table 104. Eli Lilly Revenue in Uterine Fibroids Business (2018-2023) & (US$ Million)

    Table 105. Eli Lilly Recent Development

    Table 106. GlaxoSmithKline Pharmaceuticals Company Detail

    Table 107. GlaxoSmithKline Pharmaceuticals Business Overview

    Table 108. GlaxoSmithKline Pharmaceuticals Uterine Fibroids Product

    Table 109. GlaxoSmithKline Pharmaceuticals Revenue in Uterine Fibroids Business (2018-2023) & (US$ Million)

    Table 110. GlaxoSmithKline Pharmaceuticals Recent Development

    Table 111. Pfizer Company Detail

    Table 112. Pfizer Business Overview

    Table 113. Pfizer Uterine Fibroids Product

    Table 114. Pfizer Revenue in Uterine Fibroids Business (2018-2023) & (US$ Million)

    Table 115. Pfizer Recent Development

    Table 116. Johnson & Johnson Company Detail

    Table 117. Johnson & Johnson Business Overview

    Table 118. Johnson & Johnson Uterine Fibroids Product

    Table 119. Johnson & Johnson Revenue in Uterine Fibroids Business (2018-2023) & (US$ Million)

    Table 120. Johnson & Johnson Recent Development

    Table 121. Novartis Company Detail

    Table 122. Novartis Business Overview

    Table 123. Novartis Uterine Fibroids Product

    Table 124. Novartis Revenue in Uterine Fibroids Business (2018-2023) & (US$ Million)

    Table 125. Novartis Recent Development

    Table 126. Research Programs/Design for This Report

    Table 127. Key Data Information from Secondary Sources

    Table 128. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Uterine Fibroids Market Size Comparison by Type (2023-2029) & (US$ Million)

    Figure 2. Global Uterine Fibroids Market Share by Type: 2022 VS 2029

    Figure 3. Non-Hormonal Treatment Features

    Figure 4. Hormonal Treatment Features

    Figure 5. Global Uterine Fibroids Market Size Comparison by Application (2023-2029) & (US$ Million)

    Figure 6. Global Uterine Fibroids Market Share by Application: 2022 VS 2029

    Figure 7. Hospitals Case Studies

    Figure 8. Ambulatory Surgical Centers Case Studies

    Figure 9. Diagnostic Centers Case Studies

    Figure 10. Others Case Studies

    Figure 11. Uterine Fibroids Report Years Considered

    Figure 12. Global Uterine Fibroids Market Size (US$ Million), Year-over-Year: 2018-2029

    Figure 13. Global Uterine Fibroids Market Size, (US$ Million), 2018 VS 2022 VS 2029

    Figure 14. Global Uterine Fibroids Market Share by Region: 2022 VS 2029

    Figure 15. Global Uterine Fibroids Market Share by Players in 2022

    Figure 16. Global Top Uterine Fibroids Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Uterine Fibroids as of 2022)

    Figure 17. The Top 10 and 5 Players Market Share by Uterine Fibroids Revenue in 2022

    Figure 18. North America Uterine Fibroids Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 19. North America Uterine Fibroids Market Share by Country (2018-2029)

    Figure 20. United States Uterine Fibroids Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 21. Canada Uterine Fibroids Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 22. Europe Uterine Fibroids Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 23. Europe Uterine Fibroids Market Share by Country (2018-2029)

    Figure 24. Germany Uterine Fibroids Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 25. France Uterine Fibroids Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 26. U.K. Uterine Fibroids Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 27. Italy Uterine Fibroids Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 28. Russia Uterine Fibroids Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 29. Nordic Countries Uterine Fibroids Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 30. Asia-Pacific Uterine Fibroids Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 31. Asia-Pacific Uterine Fibroids Market Share by Region (2018-2029)

    Figure 32. China Uterine Fibroids Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 33. Japan Uterine Fibroids Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 34. South Korea Uterine Fibroids Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 35. Southeast Asia Uterine Fibroids Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 36. India Uterine Fibroids Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 37. Australia Uterine Fibroids Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 38. Latin America Uterine Fibroids Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 39. Latin America Uterine Fibroids Market Share by Country (2018-2029)

    Figure 40. Mexico Uterine Fibroids Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 41. Brazil Uterine Fibroids Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 42. Middle East & Africa Uterine Fibroids Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 43. Middle East & Africa Uterine Fibroids Market Share by Country (2018-2029)

    Figure 44. Turkey Uterine Fibroids Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 45. Saudi Arabia Uterine Fibroids Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 46. Boston Scientific Revenue Growth Rate in Uterine Fibroids Business (2018-2023)

    Figure 47. Cooper Surgical Revenue Growth Rate in Uterine Fibroids Business (2018-2023)

    Figure 48. C.R. Bard Revenue Growth Rate in Uterine Fibroids Business (2018-2023)

    Figure 49. F. Hoffmann-La Roche Revenue Growth Rate in Uterine Fibroids Business (2018-2023)

    Figure 50. GE Healthcare Revenue Growth Rate in Uterine Fibroids Business (2018-2023)

    Figure 51. Karl Storz Endoscopy Revenue Growth Rate in Uterine Fibroids Business (2018-2023)

    Figure 52. Richard Wolf Medical Instruments Revenue Growth Rate in Uterine Fibroids Business (2018-2023)

    Figure 53. Siemens Medical Solutions Revenue Growth Rate in Uterine Fibroids Business (2018-2023)

    Figure 54. AbbVie Revenue Growth Rate in Uterine Fibroids Business (2018-2023)

    Figure 55. AstraZeneca Revenue Growth Rate in Uterine Fibroids Business (2018-2023)

    Figure 56. Bayer Revenue Growth Rate in Uterine Fibroids Business (2018-2023)

    Figure 57. Eli Lilly Revenue Growth Rate in Uterine Fibroids Business (2018-2023)

    Figure 58. GlaxoSmithKline Pharmaceuticals Revenue Growth Rate in Uterine Fibroids Business (2018-2023)

    Figure 59. Pfizer Revenue Growth Rate in Uterine Fibroids Business (2018-2023)

    Figure 60. Johnson & Johnson Revenue Growth Rate in Uterine Fibroids Business (2018-2023)

    Figure 61. Novartis Revenue Growth Rate in Uterine Fibroids Business (2018-2023)

    Figure 62. Bottom-up and Top-down Approaches for This Report

    Figure 63. Data Triangulation

    Figure 64. Key Executives Interviewed